| Bioactivity | Bismuth subcitrate potassium is an antibiotic against 12 C. pyloridis strains with MIC50 of 8 ug/ml[1]. Bismuth subcitrate potassium is used to treat diseases of the upper gastrointestinal tract infected with Helicobacter pylori[2]. |
| Target | MIC50: 8 ug/ml (C. pyloridis) |
| Name | Bismuth subcitrate potassium |
| CAS | 880149-29-1 |
| Formula | C12H8BiK5O14 |
| Molar Mass | 780.66 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Van Caekenberghe DL, et al. In vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori). Antimicrob Agents Chemother. 1987 Sep;31(9):1429-30. [2]. Malfertheiner P, et al. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial. Lancet. 2011 Mar 12;377(9769):905-13. |
Bismuth subcitrate potassium
CAS: 880149-29-1 F: C12H8BiK5O14 W: 780.66
Bismuth subcitrate potassium is an antibiotic against 12 C. pyloridis strains with MIC50 of 8 ug/ml. Bismuth subcitrate
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.